v3.25.4
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Millions
Total
Total Apollo Global Management, Inc. Stockholders’ Equity (Deficit)
Common Stock
Series A Mandatory Convertible Preferred Stock
Additional Paid in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Non-Controlling Interests
Beginning balance (in shares) at Dec. 31, 2022     570,276,188          
Beginning balance at Dec. 31, 2022 $ 14,366 $ 6,640   $ 0 $ 14,982 $ (1,007) $ (7,335) $ 7,726
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Other changes in equity of non-controlling interests (250)             (250)
Accretion of redeemable non-controlling interests (15) (15)     (15)      
Liquidation of SPACs 80 80     71 9    
Issuance of common stock related to equity transactions 1,398 1,398   1,398        
Capital increase related to equity-based compensation 947 947     947      
Capital contributions 2,863             2,863
Dividends/distributions (1,894) (1,058)   (46) (241) (771)   (836)
Payments related to issuances of common stock for equity-based awards (in shares)     5,135,731          
Payments related to issuances of common stock for equity-based awards (219) (219)     41 (260)    
Repurchase of common stock (in shares)     (8,183,000)          
Repurchase of common stock (563) (563)     (563)      
Stock option and warrant exercises (in shares)     534,013          
Stock option and warrant exercises 21 21     21      
Redemption of subsidiary equity interests (580) (5)     (5)     575
Subsidiary issuance of equity interests 584 14     11   3 570
Net income (loss) 6,468 5,047   46   5,001   1,421
Other comprehensive income (loss) 2,027 1,757         1,757 270
Ending balance (in shares) at Dec. 31, 2023     567,762,932          
Ending balance at Dec. 31, 2023 25,233 14,044   1,398 15,249 2,972 (5,575) 11,189
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Consolidation/deconsolidation of VIEs 53             53
Issuance of warrants 109 109     109      
Other changes in equity of non-controlling interests 13             13
Accretion of redeemable non-controlling interests (3) (3)     (3)      
Issuance of common stock related to equity transactions (in shares)     742,742          
Issuance of common stock related to equity transactions 84 84     84      
Capital increase related to equity-based compensation 649 649     649      
Capital contributions 3,136             3,136
Dividends/distributions (3,578) (1,189)   (97)   (1,092)   (2,389)
Payments related to issuances of common stock for equity-based awards (in shares)     4,696,064          
Payments related to issuances of common stock for equity-based awards (286) (286)     52 (338)    
Repurchase of common stock (in shares)     (7,845,000)          
Repurchase of common stock (894) (894)     (894)      
Stock option and warrant exercises (in shares)     382,195          
Stock option and warrant exercises 15 15     15      
Subsidiary issuance of equity interests 78 66     66     12
Net income (loss) 6,373 4,577   97   4,480   1,796
Other comprehensive income (loss) $ (18) 81         81 (99)
Ending balance (in shares) at Dec. 31, 2024 565,738,933   565,738,933          
Ending balance at Dec. 31, 2024 $ 30,964 17,253   1,398 15,327 6,022 (5,494) 13,711
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Consolidation/deconsolidation of VIEs 1,598             1,598
Issuance of warrants 54 54     54      
Acquisition of Bridge (in shares)     9,754,972          
Acquisition of Bridge 1,846 1,357     1,357     489
Other changes in equity of non-controlling interests (2)             (2)
Accretion of redeemable non-controlling interests 5 5     5      
Issuance of common stock related to equity transactions (in shares)     540,177          
Issuance of common stock to donor-advised fund (in shares)     1,213,003          
Issuance of common stock to donor-advised fund 200 200     200      
Capital increase related to equity-based compensation 710 710     710      
Capital contributions 2,963             2,963
Dividends/distributions (3,282) (1,298)   (97)   (1,201)   (1,984)
Payments related to issuances of common stock for equity-based awards (in shares)     5,883,305          
Payments related to issuances of common stock for equity-based awards (527) (527)     55 (582)    
Repurchase of common stock (in shares)     (5,708,804)          
Repurchase of common stock (773) (773)     (773)      
Stock option and warrant exercises (in shares)     1,559,812          
Stock option and warrant exercises 19 19     19      
Net income (loss) 5,401 3,492   97   3,395   1,909
Other comprehensive income (loss) $ 3,339 2,849         2,849 490
Ending balance (in shares) at Dec. 31, 2025 578,981,398   578,981,398          
Ending balance at Dec. 31, 2025 $ 42,515 $ 23,341   $ 1,398 $ 16,954 $ 7,634 $ (2,645) $ 19,174